Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

Stopped early

Conditions studied: AMN, AMN Gene Mutation, X-ALD

In brief

The course of AMN-related disabilities over time is poorly or incompletely understood due to a limited number of patients and lack of treatments. This study will help obtain a better understanding of the progression of disease with AMN and facilitate efficient clinical development of future interventional medications.

Key facts

Study ID
NCT05008874
Run by
SwanBio Therapeutics, Inc.
People needed
65
Starts
2021-06-21
Expected to finish
2025-05-16
Last updated by the study team
2025-10-30

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.